Achieve Life Sciences Stock (NASDAQ:ACHV)


Chart

Previous Close

$5.00

52W Range

$1.84 - $5.78

50D Avg

$3.29

200D Avg

$2.97

Market Cap

$239.17M

Avg Vol (3M)

$1.49M

Beta

1.58

Div Yield

-

ACHV Company Profile


Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

CA

Employees

25

IPO Date

Oct 12, 1995

Website

ACHV Performance


Latest Earnings Call Transcripts


Q2 22Aug 11, 22 | 11:06 PM
Q1 22May 12, 22 | 8:08 PM
Q4 21Mar 10, 22 | 6:04 PM

Peer Comparison


TickerCompany
IPHAInnate Pharma S.A.
APLTApplied Therapeutics, Inc.
ANROAlto Neuroscience, Inc.
ELTXElicio Therapeutics, Inc.
MCRBSeres Therapeutics, Inc.
MISTMilestone Pharmaceuticals Inc.
CRDFCardiff Oncology, Inc.
TickerGate Footer Logo

Tickergate is an advanced stock research & comparison platform for informed data-driven investment decisions. 100% customizable, institutional-grade data, easy to use.

Company

AboutContact

Connect

LinkedIn

©2025 Tickergate

Tickergate does not provide financial advices and does not issue recommendations or offers to buy stocks of sell any securities. Information is provided 'as-is' and solely for informational purposes as an advice. Tickergate does not bear any responsibility or any losses or damages that may occur as a result of reliance on this data.
Start a conversation

Ask me anything about stocks, markets, or financial data.

Market Trends
Compare Stocks